An exploratory open- label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas

被引：14
|
作者：
Tran, Duy Cong [1 ]
Moffat, Ann [1 ]
Brotherton, Richard [1 ]
Pague, Alana [1 ]
Zhu, Gefei Alex [1 ]
Chang, Anne Lynn S. [1 ]
机构：
[1] Stanford Univ, Sch Med, Dept Dermatol, 450 Broadway St, Redwood City, CA 94063 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 78卷 / 05期
关键词：
D O I：
10.1016/j.jaad.2017.11.031
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1011 / 1013
页数：4
相关论文
共 50 条
  • [1] An exploratory, open-label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas
    Duy Tran
    Zhu, Alex
    Chang, Anne Lynn
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB38 - AB38
  • [2] An open-label investigator initiated study to evaluate the efficacy and safety of sonidegib and buparlisib in advanced basal cell carcinomas (NCT02303041)
    Tran, D. C.
    Zhu, G.
    Chang, A. L. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S58 - S58
  • [3] An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib
    Danial, Christina
    Sarin, Kavita Y.
    Oro, Anthony E.
    Chang, Anne Lynn S.
    CLINICAL CANCER RESEARCH, 2016, 22 (06) : 1325 - 1329
  • [4] A phase 1b, open-label, investigator-initiated, proof-of-concept study of pembrolizumab for advanced basal cell carcinomas
    Chang, Anne
    Duy Tran
    Cannon, John
    Li, Shufeng
    Jeng, Mark
    Rieger, Kerri
    Reddy, Sunil
    Sarin, Kavita
    Colevas, Dimitrios
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB8 - AB8
  • [5] A Phase 2, Open-label, Investigator-initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects with Recalcitrant Contact or Atopic Dermatitis
    Volf, Eva
    Au, Shiu-Chung
    Dumont, Nicole
    Gottlieb, Alice
    CLINICAL IMMUNOLOGY, 2010, 135 : S107 - S107
  • [6] A Phase 2, Open-Label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects With Recalcitrant Allergic Contact or Atopic Dermatitis
    Volf, Eva M.
    Au, Shiu-Chung
    Dumont, Nicole
    Scheinman, Pamela
    Gottlieb, Alice B.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (03) : 341 - 346
  • [7] Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study
    Chang, Anne Lynn S.
    Tran, Duy C.
    Cannon, John G. D.
    Li, Shufeng
    Jeng, Mark
    Patel, Roma
    Van der Bokke, Lindsay
    Pague, Alana
    Brotherton, Richard
    Rieger, Kerri E.
    Satpathy, Ansuman T.
    Yost, Kathryn E.
    Reddy, Sunil
    Sarin, Kavita
    Colevas, A. Dimitrios
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (02) : 564 - 566
  • [8] Winning Poster: A Phase 2, Open-Label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects with Recalcitrant Contact or Atopic Dermatitis
    Volf, Eva
    JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (08) : 928 - 928
  • [9] An investigator-initiated, open-label study evaluating the efficacy and safety of ustekinumab in patients with moderate to severe palmar plantar psoriasis
    Wang, A. C.
    Kerensky, T. A.
    Au, S.
    Yaniv, S.
    Michelon, H.
    Andrews, I.
    Dumont, N.
    Gottlieb, A. B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S84 - S84
  • [10] An investigator-initiated, open-label study evaluating the efficacy and safety of ustekinumab in patients with moderate to severe palmar plantar psoriasis
    Yaniv, Shimrat
    Gottlieb, Alice
    Wang, Andrew
    Michelon, Melissa
    Dumont, Nicole
    Au, Shiu-chung
    Kerensky, Todd
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB185 - AB185
12345